NCT02320305 2020-01-14MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by SurgeryMayo ClinicPhase EARLY_PHASE1 Completed23 enrolled